ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2112

Physical Activity in a Cohort of Patients with Rheumatoid Arthritis

Patricia Dominguez Leiva1, Joan Manuel Dapeña1, Juan Manuel Bande1, Maria Alejandra Medina1, José caracciolo1, Diana Klajn1, Julieta Morbiducci2, Anastasia Secco3, Julia Sosa4, María Paula Kohan4, Dora Pereira5 and Silvia Papasidero1, 1Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 2Hospital General de Agudos Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 3Hospital General de Agudos Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, CABA, Argentina, 4Hospital Raúl F. Larcade, Provincia de Buenos Aires, Buenos Aires, Argentina, 5Instituto Raquis, La Plata, Argentina

Meeting: ACR Convergence 2023

Keywords: Health Care, physical activity, quality of life, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Physical activity has numerous benefits for Rheumatoid Arthritis (RA) patients such as reducing symptoms like fatigue and pain and improving physical function. The International Physical Activity Questionnaire – Short Form (IPAQ-SF) is a widely used self-administered questionnaire consisting of seven items that measures physical activity levels in minutes and metabolic equivalents (METs) over the previous week. The aim of this study was to evaluate physical activity levels in RA patients and explore potential associations with patient characteristics, disease activity, functional capacity, quality of life, anxiety, depression, and treatment.

Methods: Multicenter, analytical, observational, cross-sectional study. Patients ≥ 18 years old with a diagnosis of RA (ACR-EULAR 2010) were included. Sociodemographic data, habits, comorbidities, body mass index (BMI), RA characteristics, Clinimetrics measures and treatment were collected. In addition, participant’s physical activity levels were assessed using the IPAQ-SF. Statistical analysis:Descriptive statistics. The results of IPAQ-SF were compared according to patient characteristics, disease activity, functional capacity, quality of life, anxiety, depressionand treatment by means of an appropriate test: Student T-test, Wilcoxon, Pearson, ANOVA, or Spearman. Significance level was set at 0.05.

Results: A total of 101 patients from five centers were included. Patient characteristics are shown in Table 1. Results of clinical measurements can be observed in Table 2 and RA treatment in the Figure.A total of 31% practiced sports, with a mean of 24 months (SD 8.5). The IPAQ-SF reported a median total physical activity of 1386 METs (IQR 594-3066), with an average frequency of 7 days (IQR 3-7) and 119 minutes (SD 94.9) per week: 42% had low activity, 31% moderate, and 28% high. Median sitting time was 4.4 hours per day (IQR 2-7). Total METs median was associated with higher education (p=0.008) and sports practice (p< 0.0001). Correlation was negative with BMI (p=0.01), functional class (FC, p=0.002), P-VAS (p=0.008), PtGA-VAS (p=0.01), fatigue VAS (p=0.02), DAS28 (p=0.009) and HAQ-A (p< 0.0001). Mean total MET was higher in patients who didn’t required assistance in daily activities (p=0.0005). In addition, weekly physical activity minutes showed a negative association with PtGA-VAS (p=0.02). A higher minute mean was observed in those who practiced sports (p=0.0001), had no comorbidities (p=0.04) and didn’t need assistance (p=0.01). Physical activity day mean was higher in non-smokers (p=0.02), sports players (p=0.002), those with no erosive disease (p=0.002) and those with no need for assistance (p=0.001). High physical activity was linked to no comorbidities (p=0.02), sport practice (p< 0.001) and no assistance need (p=0.004). Patients without corticosteroids (p=0.012) and no erosive disease (p=0.012) showed more moderate/high physical activity.

Conclusion: Fifty-eight percent of the patients had moderate/high physical activity, positively associated with sports, lower RA activity and better function. Fewer comorbidities and glucocorticoid treatment were observed in this RA cohort.

Supporting image 1

Table 1. Patient characteristics (N=101)

Supporting image 2

Table 2. Results of clinical measurements (N=101)

Supporting image 3

Figure. Treatment of RA (N=101)


Disclosures: P. Dominguez Leiva: None; J. Dapeña: None; J. Bande: None; M. Medina: None; J. caracciolo: None; D. Klajn: None; J. Morbiducci: None; A. Secco: None; J. Sosa: None; M. Kohan: None; D. Pereira: None; S. Papasidero: None.

To cite this abstract in AMA style:

Dominguez Leiva P, Dapeña J, Bande J, Medina M, caracciolo J, Klajn D, Morbiducci J, Secco A, Sosa J, Kohan M, Pereira D, Papasidero S. Physical Activity in a Cohort of Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/physical-activity-in-a-cohort-of-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-activity-in-a-cohort-of-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology